| Literature DB >> 18397747 |
Edouard G Stanley1, Andrew G Elefanty.
Abstract
Type 1 diabetes represents an attractive target for human embryonic stem cell (hESC)-based cell replacement therapies. Recently, in Nature Biotechnology, Kroon et al. (2008) reported encouraging progress toward this goal with the development of functional islet-like structures in mice transplanted with hESC-derived pancreatic endoderm.Entities:
Mesh：
Year: 2008 PMID： 18397747 DOI： 10.1016/j.stem.2008.03.011
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633